Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rosiglitazone Causes Cardiotoxicity via Peroxisome Proliferator-Activated Receptor γ-Independent Mitochondrial Oxidative Stress in Mouse Hearts
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 138, Issue 2, Pages 468-481
Publisher
Oxford University Press (OUP)
Online
2014-01-22
DOI
10.1093/toxsci/kfu015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion
- (2013) Siripong Palee et al. EXPERIMENTAL PHYSIOLOGY
- Mitochondria as a Source of Reactive Oxygen and Nitrogen Species: From Molecular Mechanisms to Human Health
- (2012) Tiago R. Figueira et al. ANTIOXIDANTS & REDOX SIGNALING
- Chemical Proteomics-Based Analysis of Off-Target Binding Profiles for Rosiglitazone and Pioglitazone: Clues for Assessing Potential for Cardiotoxicity
- (2012) Brian R. Hoffmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitochondria are an early target of oxidative modifications in senescing legume nodules
- (2012) Manuel A. Matamoros et al. NEW PHYTOLOGIST
- Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart
- (2011) Ethan J Anderson et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
- (2011) Siripong Palee et al. EXPERIMENTAL PHYSIOLOGY
- Peroxisome Proliferator-Activated Receptor δ Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart
- (2010) Peiyong Wang et al. CIRCULATION RESEARCH
- Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes
- (2010) R. Rabøl et al. DIABETES OBESITY & METABOLISM
- Type 2 diabetes, thiazolidinediones, and cardiovascular risk
- (2009) Clare Taylor et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: role of oxidative stress and PRMT-1
- (2009) Carmine Savoia et al. CLINICAL SCIENCE
- Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes
- (2009) Lyudmila I. Rachek et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Redox Regulation of Cell Survival
- (2008) Dunyaporn Trachootham et al. ANTIOXIDANTS & REDOX SIGNALING
- Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy
- (2008) Wolfgang C. Winkelmayer et al. ARCHIVES OF INTERNAL MEDICINE
- The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic rats
- (2008) Servet Kavak et al. CELL BIOCHEMISTRY AND FUNCTION
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ-INDEPENDENT EFFECTS OF THIAZOLIDINEDIONES ON HUMAN CARDIAC MYOFIBROBLAST FUNCTION
- (2008) Romana S Mughal et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease
- (2008) Helene Von Bibra et al. Diabetes & Vascular Disease Research
- The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals
- (2008) Patrick J. Manning et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Rosiglitazone Stimulates Nitric Oxide Synthesis in Human Aortic Endothelial Cells via AMP-activated Protein Kinase
- (2008) James G. Boyle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria
- (2008) Carley R. Benton et al. JOURNAL OF PHYSIOLOGY-LONDON
- The Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor-α–Dependent Manner In Vitro and In Vivo in Mice
- (2008) Gabriela Orasanu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started